Copthorne Tara Hotel, London, UK (May 11-13, 2020)
About HPAPI
SMi is delighted to announce its 4th Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 11th – 12th May 2020.
HPAPI 2020 conference focuses on the growing landscape driven by the demand for highly potent drugs in oncology, diabetes and autoimmune disease treatment. This event will address the biggest challenges the industry is facing with regards to determining toxicology limits, assessing hazards, implementing risk procures, translating risk assessment into facility engineering, preventing and dealing with cross-contamination and adhering to GMP regulatory guidelines.
Attend the conference and join our networking platform for industry professionals to provide you with the expertise to overcome the challenges of the HPAPI industry.
Network and learn from leading professionals such as:
CHAIR FOR 2020 - Justin Mason-Home, Director, HPAPI Project Services Limited
KEY SPEAKERS INCLUDE:
Pascal Michoux, Vice President, Global EHS Teva api & Biologics, teva API Italy
William Hawkins, Manager Occupation Toxicology, GsK
Brian Edwards, Chair, Pharmaceutical Human Factors Group, CIeHf
Thomas Adam, Head of GQA Chemical APIs, Bayer AG
Ildikó Ziegler, QA Manager, Gedeon Richter
Francois D’Hooge, ADC Project Manager, Gamamabs Pharma
Andreas Schreiner, Head of Validation, Novartis
FEATURED HIGHLIGHTS:
View the full agenda: www.highlypotentapi.com/GTBio
Additional Contact Info:
T: +44 (0) 20 7827 6164
Gate2Biotech - Biotechnologický portál - Vše o biotechnologiích na jednom místě.
ISSN 1802-2685
Tvorba webových stránek: CREOS CZ
© 2006 - 2024 Jihočeská agentura pro podporu inovačního podnikání o.p.s.
Zajímavé články s biotechnologickým obsahem:
Brigády pro studenty - Brigády pro studenty. Nabídky zajímavé práce z celé ČR
Práce na vedlejší pracovní poměr
Nanovločky oxidu grafenu omezují toxicitu proteinů Alzheimerovy choroby
Nový palivový článek těží energii z půdních mikrobů